Andreas Lysandropoulos

725 total citations
21 papers, 521 citations indexed

About

Andreas Lysandropoulos is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Andreas Lysandropoulos has authored 21 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Andreas Lysandropoulos's work include Multiple Sclerosis Research Studies (14 papers), Polyomavirus and related diseases (4 papers) and Immunotherapy and Immune Responses (4 papers). Andreas Lysandropoulos is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Polyomavirus and related diseases (4 papers) and Immunotherapy and Immune Responses (4 papers). Andreas Lysandropoulos collaborates with scholars based in Belgium, Switzerland and United States. Andreas Lysandropoulos's co-authors include Renaud Du Pasquier, Myriam Schluep, Giuseppe Pantaleo, Samantha Jilek, Eva Havrdová, Mathieu Canales, Pascal Meylan, Hans H. Hirsch, Laurence Guignard and Fleur Samantha Benghiat and has published in prestigious journals such as The Journal of Immunology, The Lancet Neurology and European Journal of Immunology.

In The Last Decade

Andreas Lysandropoulos

21 papers receiving 513 citations

Peers

Andreas Lysandropoulos
Stéphanie Jurgensen United States
Owen Pearson United Kingdom
Emilie Sundqvist Sweden
Salim Chahin United States
Antonio Cortese Italy
Sarah Laurent Germany
E Bartholomé Belgium
Howard Rossman United States
Valeria Barcella Italy
Damien Biotti France
Stéphanie Jurgensen United States
Andreas Lysandropoulos
Citations per year, relative to Andreas Lysandropoulos Andreas Lysandropoulos (= 1×) peers Stéphanie Jurgensen

Countries citing papers authored by Andreas Lysandropoulos

Since Specialization
Citations

This map shows the geographic impact of Andreas Lysandropoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Lysandropoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Lysandropoulos more than expected).

Fields of papers citing papers by Andreas Lysandropoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Lysandropoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Lysandropoulos. The network helps show where Andreas Lysandropoulos may publish in the future.

Co-authorship network of co-authors of Andreas Lysandropoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Lysandropoulos. A scholar is included among the top collaborators of Andreas Lysandropoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Lysandropoulos. Andreas Lysandropoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lysandropoulos, Andreas, Gaetano Perrotta, Thibo Billiet, et al.. (2019). Human Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis Prognosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 47(2). 189–196. 7 indexed citations
3.
4.
D’hooghe, Marie, Geert Van Gassen, Daphne Kos, et al.. (2018). Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study. Multiple Sclerosis and Related Disorders. 22. 90–96. 43 indexed citations
5.
Lambert, Catherine, Bénédicte Dubois, Dominique Dive, et al.. (2018). Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus. Acta Neurologica Belgica. 118(1). 7–11. 9 indexed citations
6.
Lysandropoulos, Andreas, Nicolas Mavroudakis, Massimo Pandolfo, et al.. (2017). HLA genotype as a marker of multiple sclerosis prognosis: A pilot study. Journal of the Neurological Sciences. 375. 348–354. 9 indexed citations
7.
Sprangers, Ben, D. Decoo, Dominique Dive, et al.. (2017). Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensus. Acta Neurologica Belgica. 118(2). 143–151. 10 indexed citations
8.
Lysandropoulos, Andreas, et al.. (2016). Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients. Acta Neurologica Belgica. 117(1). 61–65. 4 indexed citations
9.
Lysandropoulos, Andreas, et al.. (2016). Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases. Clinical Therapeutics. 38(3). 670–675. 10 indexed citations
10.
Lysandropoulos, Andreas, Julie Absil, Thierry Metens, et al.. (2016). Quantifying brain volumes for Multiple Sclerosis patients follow‐up in clinical practice – comparison of 1.5 and 3 Tesla magnetic resonance imaging. Brain and Behavior. 6(2). e00422–e00422. 26 indexed citations
11.
Lysandropoulos, Andreas & Fleur Samantha Benghiat. (2013). Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient. Multiple Sclerosis Journal. 19(11). 1551–1552. 13 indexed citations
12.
Jilek, Samantha, Amandine Mathias, Mathieu Canales, et al.. (2013). Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients. Multiple Sclerosis Journal. 20(7). 837–842. 17 indexed citations
13.
Lysandropoulos, Andreas & Nicolas Mavroudakis. (2012). Exacerbation of myasthenia gravis after postoperative radiotherapy for a thymoma. Acta Neurologica Belgica. 112(1). 65–66. 3 indexed citations
14.
Jilek, Samantha, Myriam Schluep, Alexandre Harari, et al.. (2012). HLA-B7–Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis. The Journal of Immunology. 188(9). 4671–4680. 39 indexed citations
15.
Jilek, Samantha, Myriam Schluep, Pascal Meylan, et al.. (2011). Correction: Intrathecal immune responses to EBV in early MS. European Journal of Immunology. 41(5). 1501–1501. 1 indexed citations
16.
Lysandropoulos, Andreas & Renaud Du Pasquier. (2010). Demyelination as a complication of new immunomodulatory treatments. Current Opinion in Neurology. 23(3). 226–233. 17 indexed citations
17.
Jilek, Samantha, Hans H. Hirsch, Andreas Lysandropoulos, et al.. (2010). Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. The Lancet Neurology. 9(3). 264–272. 73 indexed citations
18.
Lysandropoulos, Andreas & Andrea O. Rossetti. (2010). Postictal cortical visual impairment: A symptom of posterior reversible encephalopathy. Epilepsy & Behavior. 17(2). 276–277. 2 indexed citations
19.
Lysandropoulos, Andreas, et al.. (2010). Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects. Journal of Neuroimmunology. 233(1-2). 240–244. 75 indexed citations
20.
Jilek, Samantha, Myriam Schluep, Pascal Meylan, et al.. (2009). Intrathecal immune responses to EBV in early MS. European Journal of Immunology. 40(3). 878–887. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphanie Jurgensen Breakdown of academic impact, for papers by Owen Pearson Breakdown of academic impact, for papers by Emilie Sundqvist Breakdown of academic impact, for papers by Salim Chahin Breakdown of academic impact, for papers by Antonio Cortese Breakdown of academic impact, for papers by Sarah Laurent Breakdown of academic impact, for papers by E Bartholomé Breakdown of academic impact, for papers by Howard Rossman Breakdown of academic impact, for papers by Valeria Barcella Breakdown of academic impact, for papers by Damien Biotti
Rankless by CCL
2026